Category: Smith & Nephew
Here's a look at some of the top legal news stories for medical device companies this week: Another Covidien shareholder sues to block Medtronic merger; Ex-Integra sales rep, manager cop to $800k hospital fraud scheme; Diabetes: Medtronic, Johnson & Johnson settle patent spat; Stryker settles hip implant suit against J&J's DePuy; Appeals court reverses Medtronic's win in Lenox bone mill spat
Wright Medical Group Inc.
, Zimmer Holdings
, DePuy Synthes
, Integra LifeSciences Corp.
, Johnson & Johnson
, Lenox MacLaren Surgical Corp.
, Smith & Nephew
, Stryker Corp.
Stryker Corp. settles a patent infringement lawsuit filed against Johnson & Johnson's DePuy Orthopaedics division; co-defendants Wright Medical, Zimmer Holdings and Smith & Nephew move to have their cases tossed as well.
One analyst still sees potential for a Stryker merger with Smith & Nephew, even though S&N CEO Olivier Bohuon says he's not up for it.
Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M
Smith & Nephew CEO Olivier Bohuon says the company is under no pressure to be acquired after at least 10 years as a prominent M&A target.
Smith & Nephew (FTSE:SN, NYSE:SNN) isn't in a big rush to jump on the mega-merger bandwagon, CEO Olivier Bohuon said today.
Smith & Nephew's new, 'no-frills' Syncera program aims to cut orthopedic medical device prices in half for a slice of the U.S. hospital market.
Smith & Nephew confirms that it's cutting some of its U.K. manufacturing jobs and moving the positions to a plant in China.